纳米技术用于促进卵巢癌免疫疗法免疫疗法
Prabhjot Kaur1, Santosh Kumar Singh1, Manoj K Mishra2
1Department of Microbiology, Biochemistry and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA, 30310, USA.
Journal of ovarian research
|October 14, 2024
概括
卵巢癌很难在早期发现,导致结果不佳. 先进的免疫疗法和纳米技术为克服治疗耐药性和改善患者存活率提供了新的希望.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症免疫学 癌症免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 卵巢癌是妇科癌症死亡的主要原因,由于模糊的症状,经常被诊断为晚期.
- 在标准治疗 (手术,化疗) 后,高复发率 (50-75%) 需要新的治疗策略.
- 由于免疫抑制瘤微环境,目前的免疫疗法在卵巢癌中面临挑战.
研究的目的:
- 突出迫切需要改善卵巢癌的诊断和治疗选择.
- 探索先进免疫疗法和纳米技术在克服治疗耐药性的潜力.
- 为了解决现有治疗方法在治疗卵巢癌方面的局限性.
主要方法:
- 审查目前的卵巢癌治疗方法,包括手术和化疗.
- 在卵巢癌中分析免疫检查点抑制剂的疗效和局限性.
- 研究新兴的免疫疗法技术和基于纳米技术的输送系统.
主要成果:
- 延迟诊断和治疗阻力是导致高卵巢癌死亡率的关键因素.
- 卵巢癌中的瘤微环境通常会抑制免疫反应,限制免疫治疗的有效性.
- 基于纳米技术的输送系统显示出增强免疫疗法疗效的前景.
结论:
- 迫切需要新的方法来改善卵巢癌的早期检测和治疗结果.
- 先进的免疫疗法,特别是与纳米技术相结合时,为克服治疗耐药性提供了一个有希望的途径.
- 对这些创新策略的进一步研究对于改善卵巢癌患者存活率至关重要.
关键词:
收养细胞疗法采用细胞疗法.化学抗原受体T细胞治疗临床试验中的临床试验.免疫检查站封锁免疫检查站封锁来自骨髓细胞的抑制细胞.卵巢癌是发生在卵巢中的癌症.光动力学疗法是一种光动力学疗法.光热疗法是一种光热疗法.监管性T细胞 监管性T细胞与瘤相关的巨细胞.更多相关视频
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
2.5K
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
18.2K
相关概念视频
01:27Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:30Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K